Injectable BPC-157 enters systemic circulation and provides broader anti-inflammatory benefits, which can support gut healing indirectly but for direct mucosal repair, oral is the stronger choice
urotoday.com Older European trials: BPC-157s discoverers in Europe have claimed success in early clinical trials for inflammatory bowel disease in the 1990s
NAD+ is a critical coenzyme involved in hundreds of enzymatic reactions including glycolysis, the citric acid cycle, and oxidative phosphorylation, as well as serving as a substrate for NAD+-consuming enzymes including sirtuins, PARPs, and CD38
First Injection Quick intramuscular injection in the upper arm, thigh, or gluteal area typically less than 10 minutes
This aligns with natural GH release patterns during deep sleep